Skip to main content

Advertisement

Table 1 Liver function tests of rats under MSG-induced obesity and probiotic correction

From: Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention

Parameters Control rats (n = 10) MSG-induced obesity (n = 10) B. animalis VKL (n = 10) B. animalis VKB (n = 10) L. casei IMVB-7280 (n = 10) Poliprobiotics (n = 10) Symbiter (n = 10)
Total bilirubin, umol/l 12.9 ± 0.73 12.6 ± 0.58 13.6 ± 0.68 12.5 ± 0.3 13.3 ± 0.63 12.4 ± 0.47 13.4 ± 0.63
Indirect bilirubin, umol/l 8.3 ± 0.55 8.2 ± 0.35 8.6 ± 0.47 8.2 ± 0.29 8.5 ± 0.5 8.3 ± 0.33 8.3 ± 0.53
Direct bilirubin, mmol/l 4.6 ± 0.33 4.4 ± 0.3 5.0 ± 0.29 4.3 ± 0.26 4.8 ± 0.29 4.1 ± 0.27 5.1 ± 0.23
ALT, mkkat/l 0.231 ± 0.011 0.243 ± 0.015 0.230 ± 0.013 0.209 ± 0.010 0.221 ± 0.008 0.211 ± 0.014 0.212 ± 0.007
AST, mkkat/l 0.386 ± 0.007 0.397 ± 0.011 0.396 ± 0.015 0.382 ± 0.011 0.389 ± 0.014 0.373 ± 0.016 0.381 ± 0.018
  1. Data are presented as the M ± SEM. One-way ANOVA or Kruskall-Wallis test were performed for data analysis. All differences were not significant (p > 0.05)